packageOctreotide

octreotide

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Octreotide, a somatostatin analogue, is used to treat acromegaly and various neuroendocrine conditions such as carcinoid syndrome and pancreatic cancer. It is an approved medicine, authorised in the European Union for acromegaly, and is also being investigated for other uses.

Summary written by glm-5.3-flash from Wikidata Q419935 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:octreotide
ATC codes:H01CB02
DrugBank:DB00104
PubChem CID:448601
Wikidata:Q419935
molar mass:1019.2 g/mol (Drugs.Common 25.09, not verified)
logP:1 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown